Alternatives Flashcards
MRSA
Pattern of susceptibility of strains varies, general cross-resistance between Beta-lactam antibiotics.
Once considered noscomial, is now being isolated in community acquired infections. Clearance cantake a long time, and some may never fully be cleared.
MDR-TB
Relatively few anti-TB drugs available. M. tuberculosis has a fairly high mutation rate and resistance occurs evenin people who havent been treated before.
MDR-TB strains are resistant to at least isioniazid and rifampicin
Malaria
40% of population deemed to be at risk
Caused by the species Plasmodium
Currently no effective vaccine
Number of drugs exist but resistance to many has evolved. MDR-falciparum is widespread in SE Asia and South America and now being reported in Africa
WHO strongly recommend multi-drug therapy including one of the Artemesin family of anti-malrials
Fungi
In healthy populations, fungi pose a low risk, but are a significant threat in the immunocompromised.
Not that many antifungals available.
Opportunistic moulds often intrinsically resistant to a number of antifungals.
Acquired resistance is becoming an issue, especially in azole resistant Candida species.
MDR being reported in Candida and Aspergillus
HIV
Viral agent of AIDS
Number of therapied available
Usually starting from most tolerable drug downwards.
Resistance being reported in patients who have previously received therapy, and those who havent.
Evolution of resistance in an individual patient is fairly rapid and there is need to sequence the order in which drugs are given.
Significant resistance Problems:
Extended beta-lactamase production in Enterobacteriaceae and more recently carbapenemase producing Enterobacteriaceae.
Emergence of Acinetobacter bamaunii as a noscomial infection.
Increasing importance of intrinsically resistant microbes in infection of immunocompromised e.g. Pseudomonas in Cystic fibrosis.
Resistance to the best drugs for certain infections For example, only certain drugs cross the BBB well enough to be first line drugs to meningitis, however resistance is becoming an issue in the major causes of meningitis.
Reclaiming the drugs we have:
Stop empiric therapy Rotation of empiric therapy Holding some drugs for specific uses Using drugs currently only used topically for other infections. (colistin) Further reducing prescription Stopping over the counter sales
Some of these ideas would potentially increase number of circulating pathogens while people were not being treated until lab tests were performed. Also a disincentive to pharma companies
DOTS strategy to fight TB: 5 requirements
Directly observed treatment, short course.
- ) Sustained political and financial commitment
- ) Diagnosis quality ensured sputum-smear microscopy
- ) Standardised short-course anti-TB treatment given under direct and supportive observation
- ) A regular, uninterrupted supply of high quality anti-TB drugs available to all.
- ) Standardised recording and reporting.
Vaccination:
Currently, vaccination is an important defence against infectious diseases. Particularly when the disease has serious outcomes, where its common, where other treatments are less optimal (or no other treatment).
Vaccination has succesfully eradicated smallpox and polio is nearly gone.
A bigger role for vaccination?
Easier said than done
devleopment costs, trials, approval, litigation
Many infections are endogenous
Impact on normal flora may lead to new strains of infection.
Public perception issues.
Some groups cant be vaccinated.
Surgery:
Surgery, in some cases has always been used.
Use os surgery for TB has long been an option but recently in days of MDR-TB its having to be carried out more frequently and advocates say it should be done earlier to prevent spread to other lobes of the lung and reduce infectivity.
Development of new synthetic antimicrobials
Most new antibiotics are actually variations on existing molecules, often adapted with a specific function in mind, however this increases the risk of cross-resitance.
We need genuinley new classes of drugs which affect microbes in different ways to existing drugs
Other factors should be considered, like development of oral drugs which previously had to be treated in hosopitals. This would reduce the risk of spread of infection if the patient can take the drug at home, and reduce costs on healthcare where professionals previously had to administer the drug. The Dose can also be reveresed if needed through quick vomiting action.
Antimicrobial peptides;
12-50 amino acids long with general activity against both bacteria & fungi.
Many are naturally occuring in mammalian host.
Mammalian defensins are a sub-group commonly found in neutrophils (alpha) and some in gut epithelium (beta).
The potential for the development of these into usable antimicrobials is ongoing, some showing promise, particulary as topical fungal agents.
natural substances with Antimicrobial activity
A number of natural products have antimicrobial properties. The mechanism in many is not always clear, but the possibility of developing new antimicrobials from naature is ongoing. Aloe vera is a latex compound which has activity against S. aureus. Laurus nobilis is an essential oil of the Terpenoids class which has activity against some bacteria and fungi.
Garlic
One of the best characterised natural antimicrobials.
Contains the chemical Allicin, Alliumin and other sulphur compounds. Evidence has been found for activity vs Neisseria gonorrhoeae, Staph aureus and fungi.
Properties much higher in freshly squeezed garlic- many other preparations have little or no activity.
Not yet avilable in truly clinical form but som IV studies in mice have been successful.